The PI3K/Akt Pathway: Recent Progress in the Development of ATP-Competitive and Allosteric Akt Kinase Inhibitors
Journal:
Current Cancer Drug Targets
Volume:
8
Page:
7-18
Author(s):
Craig W. Lindsley, Stanley F. Barnett, Mark E. Layton and Mark T. Bilodeau
AKT Signaling in Regulating Angiogenesis
Journal:
Current Cancer Drug Targets
Volume:
8
Page:
19-26
Author(s):
Bing-Hua Jiang and Ling-Zhi Liu
Deregulation of the Akt Pathway in Human Cancer
Journal:
Current Cancer Drug Targets
Volume:
8
Page:
27-36
Author(s):
Eriko Tokunaga, Eiji Oki, Akinori Egashira, Noriaki Sadanaga, Masaru Morita, Yoshihiro Kakeji and Yoshihiko Maehara
Cellular FLICE-Like Inhibitory Protein (C-FLIP): A Novel Target for Cancer Therapy
Journal:
Current Cancer Drug Targets
Volume:
8
Page:
37-46
Author(s):
Ahmad R. Safa, Travis W. Day and Ching-Huang Wu
Inhibitors of Cyclin Dependent Kinases: Useful Targets for Cancer Treatment
Journal:
Current Cancer Drug Targets
Volume:
8
Page:
53-75
Author(s):
P. Sapra Sharma, R. Sharma and R. Tyagi
Enediyne Anticancer Antibiotic Lidamycin: Chemistry, Biology and Pharmacology
Journal:
Anti-Cancer Agents in Medicinal Chemistry
Volume:
8
Page:
123-131
Author(s):
Rong-guang Shao and Yong-su Zhen
Acetylenic Anticancer Agents
Journal:
Anti-Cancer Agents in Medicinal Chemistry
Volume:
8
Page:
132-170
Author(s):
A. Siddiq and V. Dembitsky
Targeted Tumor Diagnosis and Therapy with Peptide Hormones as Radiopharmaceuticals
Journal:
Anti-Cancer Agents in Medicinal Chemistry
Volume:
8
Page:
186-199
Author(s):
Annette G. Beck-Sickinger and Irfan Ullah Khan
Endoradiotherapy with Peptides - Status and Future Development
Journal:
Current Medicinal Chemistry
Volume:
15
Page:
219-234
Author(s):
Uwe Haberkorn, Michael Eisenhut, Annette Altmann and Walter Mier
Detection and Specific Targeting of Hypoxic Regions within Solid Tumors: Current Preclinical and Clinical Strategies
Journal:
Current Medicinal Chemistry
Volume:
15
Page:
322-338
Author(s):
M. Bache, M. Kappler, H. M. Said, A. Staab and D. Vordermark